Cannabis Stocks Slide During FDA Hearing On CBD

Major cannabis companies traded lower Friday during a Food and Drug Administration hearing on CBD products. The cannabis industry has been in a legal haze as the FDA decides how to police products with CBD. Wall Street thinks the $1 billion CBD industry could grow to $16 billion depending on how it’s regulated. Visit Market Insider’s homepage for more stories. Cannabis stocks traded lower Friday during a hearing held by the Food and Drug Administration where federal regulators will hear arguments that will inform policing of the substance cannabidiol, or CBD.

This video was produced by YT Wochit News using


%d bloggers like this: